Brazil's Anvisa gets go-ahead on regional regulatory collaborations
This article was originally published in SRA
Brazil's healthcare products regulatory agency, Anvisa (Agência Nacional de Vigilância Sanit�ria), has been given the go-ahead to enter co-operation agreements with its counterparts in Paraguay, Uruguay, Argentina and the Mercosur trading bloc1.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.